Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study

Abstract

In the majority of patients with CRPC and a symptomatic pelvic tumor, PPRT with 30-39 Gy contributes to relief of hematuria, pain and other pelvic symptoms, with acceptable toxicity. Future studies should investigate whether PPRT regimens can be simplified.